DLRHX
Price
$25.94
Change
+$0.05 (+0.19%)
Updated
Oct 17 closing price
Net Assets
678.66M
JFNIX
Price
$75.85
Change
+$0.47 (+0.62%)
Updated
Oct 17 closing price
Net Assets
4.57B
Interact to see
Advertisement

DLRHX vs JFNIX

Header iconDLRHX vs JFNIX Comparison
Open Charts DLRHX vs JFNIXBanner chart's image
Macquarie Healthcare R
Price$25.94
Change+$0.05 (+0.19%)
VolumeN/A
Net Assets678.66M
Janus Henderson Global Life Sciences I
Price$75.85
Change+$0.47 (+0.62%)
VolumeN/A
Net Assets4.57B
DLRHX vs JFNIX Comparison Chart in %
View a ticker or compare two or three
VS
DLRHX vs. JFNIX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLRHX is a Hold and JFNIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.57B vs. DLRHX (679M). JFNIX pays higher dividends than DLRHX: JFNIX (0.38) vs DLRHX (0.00). DLRHX was incepted earlier than JFNIX: DLRHX (16 years) vs JFNIX (16 years). DLRHX (1.51) is less costly to investors than JFNIX (0.77). JFNIX is a more actively managed with annual turnover of: 35.00 vs. DLRHX (5.00). DLRHX has a lower initial minimum investment than JFNIX: DLRHX (0) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -5.65 vs. DLRHX (-9.11). JFNIX return over 5 years is better than : 11.17 vs. DLRHX (-4.99).
DLRHXJFNIXDLRHX / JFNIX
Total Expense Ratio1.460.77190%
Annual Report Gross Expense Ratio1.510.77196%
Fund Existence16 years16 years-
Gain YTD12.63611.511110%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets679M4.57B15%
Annual Yield % from dividends0.000.38-
Returns for 1 year-9.11-5.65161%
Returns for 3 years4.1324.0817%
Returns for 5 years-4.9911.17-45%
Returns for 10 years32.9145.8872%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRZQX37.530.21
+0.56%
T. Rowe Price Equity Income Z
RSEDX18.240.08
+0.44%
Columbia Intrinsic Value Institutional 2
BCAIX37.620.03
+0.08%
Boston Common ESG Impact Intl
AWPYX22.04-0.06
-0.27%
AB Sustainable Intl Thematic Advisor
JOMEX15.74-0.15
-0.94%
JOHCM Emerging Mkts Discovery Advisor